GlassScriptPhysician profile
Margaret Lambert-Woolley
NPI 1528027984
$1,845.86
in general payments reported to CMS, 2019-2025
24 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $804 · 2020: $118 · 2021: $168 · 2022: $184 · 2023: $311 · 2024: $104 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.19 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $313.00 | 2019 | |
| Abbvie INC. | $220.80 | 2019-2023 | |
| Astellas Pharma US INC | $189.70 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $133.31 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.07 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $119.34 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $111.33 | 2019-2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $104.10 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $89.29 | 2023-2025 | |
| Evofem Biosciences, INC. | $72.89 | 2021-2023 | Phexxi |
| Coopersurgical, INC. | $42.99 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $38.11 | 2019-2020 | |
| Hologic Sales and Service, LLC | $31.48 | 2019-2021 | |
| Scynexis, INC. | $29.99 | 2022 | |
| Daiichi Sankyo INC. | $29.84 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $28.72 | 2019 | |
| Exact Sciences Corporation | $27.57 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $26.37 | 2019 | |
| Therapeuticsmd, INC. | $25.32 | 2019-2021 | |
| Organon LLC | $23.57 | 2024 | |
| Amag Pharmaceuticals, INC. | $14.98 | 2019 | |
| Ascend Therapeutics US, LLC | $14.84 | 2022 | |
| Agile Therapeutics, INC. | $14.04 | 2021 | |
| Myovant Sciences INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Lambert-Woolley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.